首页|江西省≥60岁老年人带状疱疹疫苗接种的影响因素病例对照研究

江西省≥60岁老年人带状疱疹疫苗接种的影响因素病例对照研究

A case-control study of factors influencing herpes zoster vaccination among people ≥60 years in Jiangxi province

扫码查看
目的 了解≥60岁老年人带状疱疹疫苗(Herpes zoster vaccine,HZV)接种的影响因素.方法 采用非匹配病例对照研究设计,在江西省2个市选择≥60岁老年人收集2022年1月-2023年12月HZV接种、HZ/HZV认知和其他因素等信息,比较各因素在HZV接种者和未接种者之间的构成,采用Logistic回归模型确定HZV接种的影响因素.结果 本研究纳入HZV接种和未接种调查对象分别为206例、211例.多因素Logistic回归分析显示,HZ/HZV认知得分高、周围人有HZ患病史和有HZV接种史、可接受疫苗价格高可促进调查对象接种HZV[OR(95%CI):1.17(1.10-1.25)、3.75(2.20-6.40)、2.88(1.63-5.09)、2.81(1.61-4.91)].结论 江西省≥60 岁老年人 HZV 接种主要受HZ/HZV认知度、周围人HZ患病史或HZV接种史、疫苗价格等因素影响;建议加强老年人HZ/HZV相关知识健康教育.
Objective To explore factors influencing herpes zoster(HZ)vaccination in people aged ≥ 60 years.Methods We used a non-matched case-control study design to collect data on HZ vaccine(HZV)administration and HZ/HZV cognition and other factors among ≥ 60-year-olds in two prefectures of Jiangxi province from January 2022 to December 2023.We compared vaccinated and non-vaccinated subjects and identified factors influencing HZV vaccination using a logistic regression model.Results The study included 206 subjects who received HZV and 211 subjects who did not receive HZV.Multivariate logistic regression analysis showed that a high HZ/HZV cognition score,being around people with a history of HZ or HZV vaccination,and an acceptable vaccine price were associated with HZV vaccination of subjects[OR(95%CI):1.17(1.10-1.25),3.75(2.20-6.40),2.88(1.63-5.09),and 2.81(1.61-4.91)].Conclusions HZV vaccination of ≥60-year-olds in Jiangxi was mainly influenced by HZ/HZV cognition,being around people with a history of HZ or HZV vaccination,and vaccine price.We suggest strengthening health education about HZ and HZV for the elderly.

Herpes zoster vaccineVaccinationInfluence factorElderly people

赵晗、郭世成、刘杰、李力、吴静

展开 >

南昌大学公共卫生学院/疾病预防与公共卫生江西省重点实验室,江西南昌 330000

江西省疾病预防控制中心免疫规划所/重大疫情防控江西省重点实验室,江西南昌 330000

中国疾病预防控制中心免疫规划中心,北京 100050

带状疱疹疫苗 疫苗接种 影响因素 老年人

2024

中国疫苗和免疫
中国疾病预防控制中心

中国疫苗和免疫

CSTPCD北大核心
影响因子:2.311
ISSN:1006-916X
年,卷(期):2024.30(4)